NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

Por van Rhee, Frits, Szmania, Susann M., Zhan, Fenghuang, Gupta, Sushil K., Pomtree, Mindy, Lin, Pei, Batchu, Ramesh B., Moreno, Amberly, Spagnoli, Guilio, Shaughnessy, John, Tricot, Guido
Publicado em 2005

Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

Por Shi, Jumei, Tricot, Guido, Szmania, Susann, Rosen, Nancy, Garg, Tarun K., Malaviarachchi, Priyangi A., Moreno, Amberly, DuPont, Bo, Hsu, Katharine C., Baxter-Lowe, Lee Ann, Cottler-Fox, Michele, Shaughnessy, John D., Barlogie, Bart, van Rhee, Frits
Publicado em 2008